The in vivo experiments indicated that butyrate could reverse the aggravation of intestinal inflammation and the accelerated tumor growth induced by HFD-FMT, and the NLRP3/Caspase-1 pathway in the colon activated by HFD-FMT was also significantly inhibited by butyrate. This evidence concerns the gene NLRP3 and neoplasm.